BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20559122)

  • 21. The use of antidesmoglein stains in Mohs micrographic surgery. A potential aid for the differentiation of basal cell carcinoma from horizontal sections of the hair follicle and folliculocentric basaloid proliferation.
    Krunic AL; Garrod DR; Viehman GE; Madani S; Buchanan MD; Clark RE
    Dermatol Surg; 1997 Jun; 23(6):463-8. PubMed ID: 9217798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does the peritumoral stroma of basal cell carcinoma recapitulate the follicular connective tissue sheath?
    Sellheyer K; Krahl D
    J Cutan Pathol; 2011 Jul; 38(7):551-9. PubMed ID: 21366662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basal cell carcinomas arising within multiple trichoepitheliomas.
    Pincus LB; McCalmont TH; Neuhaus IM; Kasper R; Oh DH
    J Cutan Pathol; 2008 Oct; 35 Suppl 1():59-64. PubMed ID: 18544067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression of p63 in basal cell carcinomas and association with histological differentiation.
    Bircan S; Candir O; Kapucoglu N; Baspinar S
    J Cutan Pathol; 2006 Apr; 33(4):293-8. PubMed ID: 16630179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.
    Abdelsayed RA; Guijarro-Rojas M; Ibrahim NA; Sangueza OP
    J Cutan Pathol; 2000 Apr; 27(4):169-75. PubMed ID: 10774937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA ploidy and cyclin D1 expression in basal cell carcinoma of the head and neck.
    Staibano S; Lo Muzio L; Pannone G; Mezza E; Argenziano G; Vetrani A; Lucariello A; Franco R; Errico ME; De Rosa G;
    Am J Clin Pathol; 2001 Jun; 115(6):805-13. PubMed ID: 11392875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOX9 expression is a general marker of basal cell carcinoma and adnexal-related neoplasms.
    Vidal VP; Ortonne N; Schedl A
    J Cutan Pathol; 2008 Apr; 35(4):373-9. PubMed ID: 18333897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
    Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E
    Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma.
    Kirchmann TT; Prieto VG; Smoller BR
    Arch Dermatol; 1994 May; 130(5):589-92. PubMed ID: 7513986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caveats in BerEP4 staining to differentiate basal and squamous cell carcinoma.
    Yu L; Galan A; McNiff JM
    J Cutan Pathol; 2009 Oct; 36(10):1074-176. PubMed ID: 19187107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunohistochemical study of calretinin in normal hair follicles and tumors with follicular differentiation].
    González-Guerra E; Requena L; Kutzner H
    Actas Dermosifiliogr; 2008; 99(6):456-63. PubMed ID: 18558053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.
    Sellheyer K; Nelson P; Kutzner H; Patel RM
    J Cutan Pathol; 2013 Apr; 40(4):363-70. PubMed ID: 23398472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.
    Ordóñez NG
    Hum Pathol; 2005 Apr; 36(4):372-80. PubMed ID: 15891998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.
    Stoebner PE; Le Gallic L; Berthe ML; Boulle N; Lallemant B; Marque M; Gaspard C; Delfour C; Lavabre-Bertrand T; Martinez J; Meunier L
    Exp Dermatol; 2008 Nov; 17(11):908-15. PubMed ID: 18341568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation between basal cell carcinoma and trichoepithelioma by immunohistochemical staining of the androgen receptor: an overview.
    Arits AH; Van Marion AM; Lohman BG; Thissen MR; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Eur J Dermatol; 2011; 21(6):870-3. PubMed ID: 21865121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the hair stem cell-specific keratin 15 in pilar tumors of the skin.
    Kanitakis J; Bourchany D; Faure M; Claudy A
    Eur J Dermatol; 1999; 9(5):363-5. PubMed ID: 10417438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of PHLDA1 (TDAG51) in basal cell carcinoma and trichoepithelioma.
    Yeh I; McCalmont TH; LeBoit PE
    Br J Dermatol; 2012 Nov; 167(5):1106-10. PubMed ID: 22958125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.
    Bartoš V
    Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokeratin 15 expression in trichoepitheliomas and a subset of basal cell carcinomas suggests they originate from hair follicle stem cells.
    Jih DM; Lyle S; Elenitsas R; Elder DE; Cotsarelis G
    J Cutan Pathol; 1999 Mar; 26(3):113-8. PubMed ID: 10235375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of KIT (CD117) in neoplasms of the head and neck: an ancillary marker for adenoid cystic carcinoma.
    Mino M; Pilch BZ; Faquin WC
    Mod Pathol; 2003 Dec; 16(12):1224-31. PubMed ID: 14681323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.